WHO Approves First Malaria Treatment for Newborns

Millions of the world's tiniest patients just got a fighting chance against one of humanity's oldest killers.

The World Health Organization announced the approval of artemether-lumefantrine, the first malaria treatment formulated specifically for newborns and infants weighing between 4.4 and 11 pounds. Until now, doctors had to use medications designed for older children, which often led to dangerous dosing errors and side effects for vulnerable babies.

This approval fills a critical gap for 30 million babies born each year in malaria zones across Africa. These infants can now receive safe, age-appropriate treatment instead of improvised doses that risked toxicity or failure.

The timing couldn't be better. WHO also approved three new rapid diagnostic tests that detect malaria strains previously invisible to standard tests. In some regions of the Horn of Africa, up to 80% of cases were being missed because the parasite had evolved to hide from conventional testing.

The new tests target a different protein that the malaria parasite cannot easily evade. Countries are now urged to switch to these alternatives when more than 5% of cases slip through undetected.

The Ripple Effect

These tools arrive as 25 countries roll out malaria vaccines and next-generation mosquito nets reach communities that need them most. Together, these innovations have prevented 2.3 billion malaria infections and saved 14 million lives since 2000.

Forty-seven countries have eliminated malaria entirely, and 37 more reported fewer than 1,000 cases last year. While global progress has slowed due to drug resistance and funding cuts, the combination of vaccines, better diagnostics, improved treatments, and protective nets shows what's possible when science meets commitment.

Dr. Tedros Adhanom Ghebreyesus, WHO Director-General, captured the moment perfectly: "Ending malaria in our lifetime is no longer a dream. It is a real possibility."

With newborns finally getting the medicine they deserve, that possibility moves closer to reality every day.